君实生物：董事长熊俊累计增持10万股A股

Core Viewpoint - Junshi Biosciences (01877) announced that its controlling shareholder and chairman, Mr. Xiong Jun, plans to increase his stake in the company by at least RMB 100 million over the next 12 months starting from April 12, 2025 [1] Group 1 - Mr. Xiong intends to purchase both A-shares and H-shares through the Shanghai Stock Exchange and Hong Kong Stock Exchange, with a minimum of RMB 50 million allocated for A-shares [1] - As of the announcement date, Mr. Xiong has already acquired 100,000 A-shares, representing approximately 0.01% of the company's total share capital, with a total transaction value of RMB 3.8384 million [1] - The share purchase plan is still in progress, and Mr. Xiong will continue to buy shares at opportune times during the implementation period of the plan [1]